Founded in 2020 by Robin Li and Wei Liu, BioMap is a pioneering life science AI company focused on protein-centric modeling. Their core mission is to revolutionize drug development through advanced biocomputing technologies. BioMap's flagship product, xTrimo, is the first and largest protein-centric large language model platform, enabling scientists to model biological systems more accurately and derive novel insights from limited data. The company serves the biopharmaceutical industry, aiming to solve critical protein-related drug development challenges.
BioMap boasts a team of over 300 international experts and has garnered attention for its innovative approach to life sciences. Notable figures affiliated with BioMap include co-founders Robin Li and Wei Liu. The company has achieved significant milestones, including the development of xTrimo, which has set new standards in the field of protein modeling. BioMap's impact is evident in its contributions to more efficient and accurate drug discovery processes, positioning it as a leader in the intersection of AI and biotechnology.
